Applied Proteomics DiscernDx to Use Applied Proteomics Assets to Explore New Dx Approaches Premium The API assets could enable more data-intensive, machine learning-based approaches to healthcare, said a principal at DiscernDx investor Khosla Ventures. Applied Proteomics Sells Assets to DiscernDx for $1.85M DiscernDx, which is backed by Khosla Ventures, stepped in to purchase API's assets after lender Square 1 Bank asserted a lien on the company late last year. Applied Proteomics Looking to Outsource Sales Operations, Expand Assay Development Premium The firm is looking for outside partners to tackle test commercialization as it begins to bring its second-generation colorectal cancer assay to market. Applied Proteomics Releasing Second-Gen Colon Cancer Test; Exploring Dried Blood Spots Premium The test, which the company aims to launch in the next few months, offers a boost in specificity compared to its existing SimpliPro Colon proteomic test. Applied Proteomics Encouraged by Early Sales of CRC Test Premium Company officials said that they have seen favorable reorder rates and coverage decisions since launching the 11-protein colorectal cancer test in late 2015. Jun 26, 2015 Applied Proteomics Prepping ELISA Version of CRC Test for Near-Term Release Premium Oct 9, 2013 Applied Proteomics, DKFZ to Collaborate on Cancer MDx Aug 23, 2013 API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts Premium Aug 23, 2013 People in the News: Thomas Bachmann, Joseph Eggler, and More Premium Aug 20, 2013 Applied Proteomics Closes $28M Series C Round Jun 28, 2013 Slow Sales Leave Some Proteomics Dx Firms Questioning Value of Large Clinical Lab Deals Premium May 10, 2013 GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic Premium Mar 29, 2013 Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay Premium Mar 7, 2013 Agilent, Applied Proteomics Partner on Development of Mass Spec-based Protein Assays Feb 10, 2012 Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery Premium Feb 10, 2012 People in the News: New Board Member, CEO at Applied Proteomics Premium Feb 7, 2012 Applied Proteomics Raises $22.5M, Moves to San Diego Dec 30, 2009 Applied Proteomics, ALS TDI Collaborating on Markers Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.